Published
Novo Nordisk is the first drugmaker to introduce a highly effective weight-loss drug, Wegovy, at a time of record obesity rates.
Lars Fruergaard Jørgensen, CEO of Novo Nordisk, discusses with Reuters Breakingviews columnist Aimee Donnellan the challenge of rapidly ramping up production of Wegovy to meet soaring demand for the breakthrough drug.
#LarsFruergaardJørgensen #NovoNordisk #Wegovy AimeeDonnellan #ReutersNewsmaker #Reuters #Live #News #business #finance
Lars Fruergaard Jørgensen, CEO of Novo Nordisk, discusses with Reuters Breakingviews columnist Aimee Donnellan the challenge of rapidly ramping up production of Wegovy to meet soaring demand for the breakthrough drug.
#LarsFruergaardJørgensen #NovoNordisk #Wegovy AimeeDonnellan #ReutersNewsmaker #Reuters #Live #News #business #finance
- Category
- World
Sign in or sign up to post comments.
Be the first to comment
Up Next
Autoplay
-
01:03
Novo Nordisk extends curbs on hot weight-loss drug
-
30:38
LIVE: Reuters NEXT Newsmaker with EQT Chief Executive Christian Sinding
-
1:01:02
LIVE: Reuters Newsmaker with AustralianSuper CEO Paul Schroder
-
47:04
LIVE: Reuters Newsmaker with Mondelez International CEO and Chairman Dirk Van de Put
-
49:09
LIVE: Reuters Newsmaker with Emma Walmsley, CEO of GlaxoSmithKline
-
1:03:17
LIVE: Reuters Newsmaker with IAC Chairman Barry Diller
-
48:38
LIVE: Reuters Newsmaker with AstraZeneca CEO Pascal Soriot
-
01:01
Novo Nordisk owner sees IPO window opening
-
50:47
LIVE: Reuters Newsmaker with FDA Commissioner Robert Califf
-
01:33
Novo Nordisk: Wegovy heart benefits due to more than weight loss
-
37:44
LIVE: Reuters Newsmaker with US Treasury Secretary Janet Yellen
-
34:20
LIVE: Reuters Newsmaker with Conagra Brands CEO Sean Connolly
-
01:26
Novo Nordisk became Europe's most valuable company
-
Business Live: Novo Nordisk raises its forecasts fuelled by high demand for weight loss drugs
-
10:47
Biden assails Trump in fiery State of the Union speech and Ozempic maker Novo Nordisk's new pill
-
19:20
How Ozempic Accidentally Made Novo Nordisk A $400B Company
-
00:46
Wegovy maker Novo Nordisk says drug cuts risk of stroke by 20% – study
-
51:00
LIVE: Reuters Newsmaker with Benedetto Vigna, CEO of Ferrari
-
LIVE: Reuters NEXT Newsmaker featuring Sergio Ermotti, CEO of UBS
-
05:17
Sectors Upclose: Novo Nordisk is ‘almost like the Nvidia of Europe’
-
01:22
Novo Nordisk launches Wegovy in Britain
-
01:22
Obesity drug maker Novo Nordisk lifts outlook again | REUTERS
Loading...